Literature DB >> 19687519

Investigating obscure gastrointestinal bleeding: capsule endoscopy or double balloon enteroscopy?

J Westerhof1, R K Weersma, J J Koornstra.   

Abstract

The possibility to visualise the small bowel has dramatically improved with the introduction of capsule endoscopy (CE) and double balloon enteroscopy (DBE). CE and DBE have become standard practice in investigating suspected diseases of the small bowel. An important reason to perform small bowel investigations is obscure gastrointestinal bleeding. To investigate obscure gastrointestinal bleeding, some advocate performing CE while others recommend DBE . In this systematic review, we provide an overview of studies in which patients with obscure gastrointestinal bleeding underwent both CE and DBE . These data show that CE and DBE have comparable diagnostic yields in the evaluation of obscure gastrointestinal bleeding of 50 to 60%. Therapeutic interventions using DBE were performed in 11 to 57% of cases. In most studies, there was good concordance between the two procedures but both techniques can be falsely negative. Given its safety, patient tolerability and ability to view the entire small bowel, CE can be recommended as the first investigation for obscure gastrointestinal bleeding, if necessary, followed by DBE . Finally, we provide an algorithm with practical guidelines for the evaluation ofobscure gastrointestinal bleeding.

Entities:  

Mesh:

Year:  2009        PMID: 19687519

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  14 in total

1.  Double-balloon enteroscopy in small bowel tumors: a Chinese single-center study.

Authors:  Wen-Guo Chen; Guo-Dong Shan; Hong Zhang; Lin Li; Min Yue; Zun Xiang; Ying Cheng; Chen-Jiao Wu; Ying Fang; Li-Hua Chen
Journal:  World J Gastroenterol       Date:  2013-06-21       Impact factor: 5.742

2.  Outcomes and safety of double-balloon enteroscopy in small bowel diseases: a single-center experience of 1531 procedures.

Authors:  Peng Wang; Yuxin Wang; Yuanhang Dong; Jiefang Guo; Hongyu Fu; Zhaoshen Li; Yiqi Du
Journal:  Surg Endosc       Date:  2020-02-18       Impact factor: 4.584

3.  Emergency double balloon enteroscopy: a feasible and promising diagnostic as well as possible therapeutic option in recurrent midgut bleeding.

Authors:  Philip Büschel; Klaus Mönkemüller; Uwe von Falkenhausen; Lucia C Fry; Peter Malfertheiner; Hans Lippert; Frank Meyer
Journal:  BMJ Case Rep       Date:  2011-03-25

Review 4.  Capsule Endoscopy in the Assessment of Obscure Gastrointestinal Bleeding: An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2015-02-01

5.  Diagnosis and treatment of small bowel diseases are advanced by capsule endoscopy and double-balloon enteroscopy.

Authors:  Hidemi Goto
Journal:  Clin J Gastroenterol       Date:  2010-08-13

Review 6.  Small bowel capsule endoscopy: Where are we after almost 15 years of use?

Authors:  Cedric Van de Bruaene; Danny De Looze; Pieter Hindryckx
Journal:  World J Gastrointest Endosc       Date:  2015-01-16

7.  Clinical Review of Small-Bowel Endoscopic Imaging.

Authors:  Michael J Bartel; Mark E Stark; Frank J Lukens
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-11

8.  Non-small-bowel abnormalities identified during small bowel capsule endoscopy.

Authors:  Reinier A Hoedemaker; Jessie Westerhof; Rinse K Weersma; Jan J Koornstra
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

9.  From Capsule Endoscopy to Balloon-Assisted Deep Enteroscopy: Exploring Small-Bowel Endoscopic Imaging.

Authors:  D Matthew Cooley; Andrew J Walker; Deepak V Gopal
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-03

10.  Degree of concordance between single balloon enteroscopy and capsule endoscopy for obscure gastrointestinal bleeding after an initial positive capsule endoscopy finding.

Authors:  Ashok Shiani; Javier Nieves; Seth Lipka; Brijesh Patel; Ambuj Kumar; Patrick Brady
Journal:  Therap Adv Gastroenterol       Date:  2016-01       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.